Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Maria Carmen Frigola Deulofeu has worked on the following 3 EPO patent applications which have been published in the last five years:

EP13710851

USE OF A PYRAZOLE DERIVATIVE IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

IPC classification:
A61K 31/415, A61P 11/00
Applicant:
Novartis AG
Agent:
Lionel Paul Clarke, Gill Jennings & Every LLP
Agent:
Maria Carmen Frigola Deulofeu, Novartis Pharma AG
Status:
PATENT GRANTED
EP12188621

GALENICAL FORMULATIONS OF ALISKIREN

IPC classification:
A61K 9/20, A61K 31/165
Applicant:
Novartis AG
Agent:
Maria Carmen Frigola Deulofeu, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12705203

DRY POWDER FORMULATIONS OF PARTICLES THAT CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATING OBSTRUCTIVE OR INFLAMMATORY AIRWAYS DISEASES

IPC classification:
A61K 9/00, A61K 9/14, A61K 9/16, A61K 9/50, A61K 31/40, A61K 31/4704, A61K 31/56, A61K 31/58, A61K 45/06, A61M 15/00, A61P 11/00
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
PATENT GRANTED

Please Sign in to use this feature